As of July 2024, Takeda Pharmaceutical Company has a market cap of $41.91B. This makes Takeda Pharmaceutical Company the world's 416th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $42.64B | 6.44% |
2023 | $40.06B | -1.39% |
2022 | $40.62B | 31.05% |
2021 | $31.00B | -16.46% |
2020 | $37.10B | -13.32% |
2019 | $42.81B | 16.92% |
2018 | $36.61B | -42.12% |
2017 | $63.25B | 32.39% |
2016 | $47.78B | -20.28% |
2015 | $59.93B | 21.38% |
2014 | $49.37B | 3.55% |
2013 | $47.68B | 25.16% |
2012 | $38.09B | 14.05% |
2011 | $33.40B | -15.39% |
2010 | $39.48B | 4.31% |
2009 | $37.85B | -17.46% |
2008 | $45.85B | -29.38% |
2007 | $64.92B | -19.58% |
2006 | $80.73B | 28.06% |
2005 | $63.04B | 23.64% |
2004 | $50.99B | 21.41% |
2003 | $42.00B | -14.31% |
2002 | $49.01B | -16.36% |
2001 | $58.60B | -12.28% |
2000 | $66.80B | - |